BridgeMD
New treatment option for Acute Heart Failure (AHF)
Official title ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure
ClinicalTrials.gov ID: NCT07484009
What this study is testing
- What it's testing
- This clinical trial aims to determine whether a ReDS-guided treatment strategy is superior to the current standard of care for adults hospitalized with heart failure. Additionally, the study will evaluate the safety and cost-effectiveness of this approach.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Hospitalized due to heart failure as the main reason, including the presence of symptoms and signs of congestion, regardless of the left ventricular...
- NT-proBNP greater than 1000 pg/L or BNP greater than 300 pg/L upon admission.
You likely can't join if
- Height less than 150 cm or greater than 190 cm or body mass index (BMI) less than 22 or greater than 39, conditions where the use of ReDS is not...
- Patients requiring inotropes (levosimendan is allowed) or vasopressors upon admission, with mechanical support, or heart transplant recipients.
- Any malformation or variant affecting the right lung anatomy (e.g., a pacemaker).
- Patients with any heart disease requiring a planned surgical intervention (CABG, valve disease, or other) or percutaneous (TAVR, STE-ACS, mitral or...
- Chronic kidney disease with a GFR \<20 or on hemodialysis.
- Life expectancy less than 12 months due to non-cardiological origin.
See the full eligibility criteria
- Hospitalized due to heart failure as the main reason, including the presence of symptoms and signs of congestion, regardless of the left ventricular ejection fraction (LVEF).
- NT-proBNP greater than 1000 pg/L or BNP greater than 300 pg/L upon admission.
- Height less than 150 cm or greater than 190 cm or body mass index (BMI) less than 22 or greater than 39, conditions where the use of ReDS is not approved.
- Patients requiring inotropes (levosimendan is allowed) or vasopressors upon admission, with mechanical support, or heart transplant recipients.
- Any malformation or variant affecting the right lung anatomy (e.g., a pacemaker).
- Patients with any heart disease requiring a planned surgical intervention (CABG, valve disease, or other) or percutaneous (TAVR, STE-ACS, mitral or tricuspid valve repair, CRT) during the clinical trial.
- Chronic kidney disease with a GFR \<20 or on hemodialysis.
- Life expectancy less than 12 months due to non-cardiological origin.
- Participation in another clinical trial with intervention.
The study team makes the final eligibility decision.
Where it's taking place
- Madrid, Madrid, Spain
- Barcelona, Spain
- Córdoba, Spain
- Girona, Spain
- Madrid, Spain
- Málaga, Spain
- Murcia, Spain
- Salamanca, Spain
- Sant Joan Despí, Spain
- Santander, Spain
- Santiago de Compostela, Spain
- Seville, Spain
- Tarragona, Spain
- Toledo, Spain
- Valencia, Spain
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Madrid, Madrid, Spain; Barcelona, Spain; Córdoba, Spain; Girona, Spain; Madrid, Spain; Málaga, Spain and 9 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.